A carregar...

The next generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner

Epigenetic agents such as bromodomain and extra terminal region inhibitors (BETi) slow tumor growth via tumor intrinsic alterations; however, their effects on anti-tumor immunity remain unclear. A recent advance is the development of next generation BETi that are potent and display a favorable half-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pigment Cell Melanoma Res
Main Authors: Erkes, Dan A., Field, Conroy O., Capparelli, Claudia, Tiago, Manoela, Purwin, Timothy J., Chervoneva, Inna, Berger, Adam C., Hartsough, Edward J., Villanueva, Jessie, Aplin, Andrew E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6697571/
https://ncbi.nlm.nih.gov/pubmed/31063649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12788
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!